mibefradil has been researched along with Ventricular Fibrillation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budihna, MV; Grasic Kuhar, C; Pleskovic, RZ | 1 |
| Hofmann, D; McCarthy, J; Muller, CA; Opie, LH; Peisach, M; Pineda, CA | 1 |
| Curtis, MJ; Farkas, A; Qureshi, A | 1 |
| Billman, GE | 1 |
4 other study(ies) available for mibefradil and Ventricular Fibrillation
| Article | Year |
|---|---|
Mibefradil is more effective than verapamil for restoring post-ischemic function of isolated hearts of guinea pigs with acute renal failure.
Topics: Acute Kidney Injury; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Electrocardiography; Guinea Pigs; Heart Rate; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Mibefradil; Myocardial Reperfusion Injury; Myocardium; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left; Verapamil | 2004 |
Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electrocardiography; Heart Ventricles; Infusions, Intravenous; Male; Mibefradil; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Swine; Tetrahydronaphthalenes; Ventricular Fibrillation; Verapamil | 1998 |
Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Electrocardiography; Heart; Heart Ventricles; Hemodynamics; In Vitro Techniques; Male; Mibefradil; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Potassium; Random Allocation; Rats; Rats, Wistar; Ventricular Fibrillation; Verapamil | 1999 |
Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Topics: Animals; Benzimidazoles; Binding Sites; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Disease Susceptibility; Dogs; Dose-Response Relationship, Drug; Heart Rate; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Physical Exertion; Tetrahydronaphthalenes; Ventricular Fibrillation; Verapamil | 1992 |